EZH2 and urinary bladder carcinoma: Specifically, EZH2 plays a crucial role in maintaining the low immunogenicity of bladder cancer cells by transcriptionally repressing cytokines and MHC class II antigen presentation genes, which leads to immune evasion and further shapes an immune-cold tumor microenvironment44.